Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
Children's Healthcare of Atlanta
ClinicalTrials.gov Identifier:
NCT00207857
First received: September 13, 2005
Last updated: February 2, 2015
Last verified: February 2015

September 13, 2005
February 2, 2015
March 2004
August 2005   (final data collection date for primary outcome measure)
PFT training [ Time Frame: 2 weeks ]
Not Provided
Complete list of historical versions of study NCT00207857 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy
Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy
Nearly all patients with Duchenne's Muscular Dystrophy (DMD) have scoliosis. Posterior instrumented spinal fusion, which is a surgery to correct scoliosis, has been shown to improve quality of life and satisfaction of both parents and families. The progressive muscular weakness leads to the development of scoliosis soon after the child has become unable to walk. The muscular weakness and scoliosis also affect the pulmonary function of these children. Pulmonary Function Tests (PFT) have been used to determine "pulmonary fitness" prior to surgery as a way to determine how well or if the child will tolerate surgery. Children with poor results on the PFT are determined to be too fragile to tolerate such a large operation. The physicians conducting this study feel that the PFT may be inaccurate and that this may not be the best single test to determine "pulmonary fitness". The physicians conducting the study think things like the time of day the study is done, how tired you are when you complete the test, and how well you understand the test may affect the results of the test.
All patients with DMD have routine PFT's every six months as standard of care. You will be randomized in to one of two groups. The group assignment will be chosen by chance, similar to flipping a coin. If you are assigned to group one you will first have your regularly scheduled PFT in the morning. You will be asked to complete a second PFT that afternoon as least 4 hours after the first PFT. You will then be asked to come back to the clinic in two weeks and repeat these PFT's, once in the morning and once in the afternoon at least 4 hours apart. Each PFT will take approximately 10 to 15 minutes. If you are assigned to group two, you will have your regularly scheduled PFT in the morning and then a second test in the afternoon at least four hours after the first test. After the second PFT you will receive training from a Respiratory Therapist. You will receive teaching handouts to take home and an incentive spirometer and peak flow meter to practice with. You will be asked to practice these tests 2 times a day and record your results. You will then be asked to come back to the clinic in two weeks to repeat 2 PFT's, once in the morning and again at least 4 hours later. All participants will be asked how they feel at the time of testing.
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
  • Duchenne's Muscular Dystrophy
  • Scoliosis
Not Provided
With and Without PFTs
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
August 2005
August 2005   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male
  • Duchenne's Muscular Dystrophy with diagnosed confirmed by a neurologist
  • No longer able to ambulate for any meaningful amount of time
  • No previous spinal operation

Exclusion Criteria:

  • Any other type of muscular dystrophy or spinal muscular atrophy
  • Tracheotomy
  • Contractures of the upper extremities that would preclude using arm span as an estimation for height
  • Previous spinal surgery
  • Asthma, recurrent pneumonia, or other chronic lung disease
Male
6 Years to 21 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00207857
Duchenne's Muscular Dystrophy
Not Provided
Not Provided
Not Provided
Not Provided
Children's Healthcare of Atlanta
Not Provided
Principal Investigator: Tim Schrader, MD Children's Orthopaedics of Atlanta
Children's Healthcare of Atlanta
February 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP